Sydney, Nov 6, 2007 (ABN Newswire) - Cathrx Ltd (ASX: CXD) - Announces Plans for New Facility - Mr Neil Anderson, CEO; Cathrx Ltd (ASX: CXD) present the following audio webcast regarding "Announces Plans for New Facility". You may also download this audio webcast to your computer or portable audio player.
Broadcaster: Cathrx Ltd (ASX: CXD)
Broadcast Title: Announces Plans for New Facility
Broadcast Type: Audio stream
Audio webcast Link:
Listen to the Audio stream and view the announcement for Cathrx Ltd (ASX: CXD) below.
http://abnnewswire.net/vlnk/S17AL58K
This Audio Cast is based on streaming audio sent in compressed form over the internet and displayed as it arrives. You do not have to wait for the whole file to be downloaded before you can hear it, instead the media is sent in a continuous stream and is played immediately as it reaches your computer. Please note that during live broadcasts there can be a delay of approximately 1-2 minutes, depending on traffic through your Internet Service Provider.
Minimum requirement for playing the multimedia links are; at least a 28.8k modem and sufficient memory and hard disk space to run Windows Media Player or Real Player. In addition, some media links contain material requiring the ability to run Flash Multimedia.
About CATHRX LTD
CathRx manufactures and markets a range of innovative catheters for the diagnosis and treatment of cardiac arrhythmias. Arrhythmias are caused by problems with the conductive pathways of the heart. They are diagnosed by using diagnostic catheters and, in some cases, cured by therapeutic cardiac catheters creating lesions on the wall of the heart designed to restore the conductive pathway to its normal rhythm.
CathRx’s European marketing strategy involves launching a series of products that work together as a system and offer cardiologists a complete catheter diagnosis and therapeutic solution. This “toolbox” is being released progressively over the next three quarters. CathRx is introducing its products to the least complex clinical procedures in the right side of the heart first before progressively addressing the more difficult clinical procedures on the left side of the heart such as atrial fibrillation. The goal in all cases is to provide the clinician with customised tools that are better suited to creating the required sensing and lesions for each specific patient in the least time possible. At the same time these catheters can provide cost efficiencies for hospitals when compared to current methods of treatment.
News 
